These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23660583)

  • 1. Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay.
    Ellis GM; Vlaskin TA; Koth A; Vaz LE; Dross SE; Beck IA; Frenkel LM
    J Virol Methods; 2013 Sep; 192(1-2):39-43. PubMed ID: 23660583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
    Dokuta S; Utaipat U; Praparattanapan J; Keitkarn J; Maneekarn N; Sirisanthana T; Supparatpinyo K
    J Virol Methods; 2013 Jun; 190(1-2):20-8. PubMed ID: 23562659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C.
    Mutsvangwa J; Beck IA; Gwanzura L; Manhanzva MT; Stranix-Chibanda L; Chipato T; Frenkel LM
    J Virol Methods; 2014 Dec; 210():36-9. PubMed ID: 25239368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing.
    Beck IA; Deng W; Payant R; Hall R; Bumgarner RE; Mullins JI; Frenkel LM
    J Clin Microbiol; 2014 Jul; 52(7):2320-7. PubMed ID: 24740080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
    Panpradist N; Beck IA; Ruth PS; Ávila-Ríos S; García-Morales C; Soto-Nava M; Tapia-Trejo D; Matías-Florentino M; Paz-Juarez HE; Del Arenal-Sanchez S; Reyes-Terán G; Lutz BR; Frenkel LM
    AIDS; 2020 Jul; 34(9):1331-1338. PubMed ID: 32205723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.
    Wagner TA; Kress CM; Beck I; Techapornroong M; Wittayapraparat P; Tansuphasawasdikul S; Jourdain G; Ngo-Giang-Huong N; Lallemant M; Frenkel LM
    J Clin Microbiol; 2010 May; 48(5):1555-61. PubMed ID: 20181911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation.
    Panpradist N; Beck IA; Chung MH; Kiarie JN; Frenkel LM; Lutz BR
    PLoS One; 2016; 11(1):e0145962. PubMed ID: 26751207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies.
    Lalonde MS; Troyer RM; Syed AR; Bulime S; Demers K; Bajunirwe F; Arts EJ
    J Clin Microbiol; 2007 Aug; 45(8):2604-15. PubMed ID: 17567789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya.
    Chung MH; Beck IA; Dross S; Tapia K; Kiarie JN; Richardson BA; Overbaugh J; Sakr SR; John-Stewart GC; Frenkel LM
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):246-53. PubMed ID: 25140907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.
    Beck IA; Crowell C; Kittoe R; Bredell H; Machaba M; Willamson C; Janssens W; Jallow S; van der Groen G; Shao Y; Jacob M; Samuel NM; de Rivera IL; Ngo-Giang-Huong N; Cassol S; Alemnji G; Frenkel LM
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):418-27. PubMed ID: 18614915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.
    Jourdain G; Wagner TA; Ngo-Giang-Huong N; Sirirungsi W; Klinbuayaem V; Fregonese F; Nantasen I; Techapornroong M; Halue G; Nilmanat A; Wittayapraparat P; Chalermpolprapa V; Pathipvanich P; Yuthavisuthi P; Frenkel LM; Lallemant M;
    Clin Infect Dis; 2010 May; 50(10):1397-404. PubMed ID: 20377404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.
    Beck IA; Mahalanabis M; Pepper G; Wright A; Hamilton S; Langston E; Frenkel LM
    J Clin Microbiol; 2002 Apr; 40(4):1413-9. PubMed ID: 11923366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors.
    Wallis CL; Mahomed I; Morris L; Chidarikire T; Stevens G; Rekhviashvili N; Stevens W
    J Virol Methods; 2005 May; 125(2):99-109. PubMed ID: 15794978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay.
    Zhang G; Cai F; Zhou Z; DeVos J; Wagar N; Diallo K; Zulu I; Wadonda-Kabondo N; Stringer JS; Weidle PJ; Ndongmo CB; Sikazwe I; Sarr A; Kagoli M; Nkengasong J; Gao F; Yang C
    J Clin Microbiol; 2013 Nov; 51(11):3666-74. PubMed ID: 23985909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
    Troyer RM; Lalonde MS; Fraundorf E; Demers KR; Kyeyune F; Mugyenyi P; Syed A; Whalen CC; Bajunirwe F; Arts EJ
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):235-50. PubMed ID: 18284323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru.
    Soria J; Mugruza R; Levine M; León SR; Arévalo J; Ticona E; Beck IA; Frenkel LM
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):150-154. PubMed ID: 30560685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.
    Chi BH; Ellis GM; Chintu N; Cantrell RA; Sinkala M; Aldrovandi GM; Warrier R; Mbewe F; Nakamura K; Stringer EM; Frenkel LM; Stringer JS
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1099-106. PubMed ID: 19886836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay.
    Villahermosa ML; Beck I; Pérez-Alvarez L; Contreras G; Frenkel LM; Osmanov S; de Parga EV; Delgado E; Manjon N; Cuevas MT; Thomson MM; Medrano L; Najera R
    J Hum Virol; 2001; 4(5):238-48. PubMed ID: 11907381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis.
    Rath BA; von Kleist M; Castillo ME; Kolevic L; Caballero P; Soto-Castellares G; Amedee AM; Robinson JE; Katzenstein DK; Van Dyke RB; Oberhelman RA
    BMC Infect Dis; 2013 Jan; 13():1. PubMed ID: 23280237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.